Safety and efficacy of a new method of percutaneous nephrolithotripsy performed under ultrasound and endovisual control without the use of intraoperative x-ray examination

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Purpose of the study. to study the safety and efficacy of using a new method of performing percutaneous nephrolithotripsy under ultrasound and endovisual control. Materials and methods. A comparative analysis of the results of percutaneous nephrolithotripsy performed under ultrasound and endovisual control in 515 (84.1%) patients (main group) and percutaneous nephrolithotripsy performed under fluoroscopic control in 97 (15.8%) patients (control group) was carried out. The groups did not differ in age, gender, body mass index, the number and location of stones, and the duration of the disease. In the main group, there were more patients with large, staghorn and X-ray negative stones, and there were also more patients with kidney block. To analyze and stratify the complications of percutaneous nephrolithotripsy, we used a modified classification of surgical complications according to the Clavien-Dindo system. Statistical analysis of the material was carried out using the licensed package IBM SPSS Statistics Version 14.0.1. Results. The average duration and number of stages of operations in the main and control groups was the same. Almost all operations in groups (93,8% и 91,8%) were performed in one step (p=0,55). In the main group, in the vast majority of cases95,1%; p<0,001), percutaneous nephrolithotripsy was performed through one puncture access, with the degree of complete elimination of stones statistically the same as in the control group (80.6% in the main group and 70.1% in the control group, p=0.158). The degree of decrease in hemoglobin in the postoperative period in the groups did not differ (p=0,271). The frequency of postoperative complications in both groups did not differ statistically: in the control - 33.0%; in the main group - 29.3% (p=0.469). The severity of complications according to Clavien-Dindo did not differ in the groups either (p=0.17). Conclusion. Percutaneous nephrolithotripsy under ultrasound and endovisual control is a safe and effective operation. The results of the operation and the frequency of early complications are comparable with the traditional X-ray control technique.

Full Text

Restricted Access

About the authors

D. V Abramov

Volga District Medical Center under Federal Medical and Biological Agency of Russia

Email: abramov-pomc@mail.ru
Head of the Department of Urology 2 CH 1 Nizhniy Novgorod, Russia

M. B Dyrdik

Volga District Medical Center under Federal Medical and Biological Agency of Russia

Email: madmmax@rambler.ru
Head of the Department of Urology CH 3 Nizhniy Novgorod, Russia

V. A Atduev

Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation; Volga District Medical Center under Federal Medical and Biological Agency of Russia

Email: atduev@mail.ru
Dr.Sc.(M), Full Prof. of the Department of Faculty Surgery and Transplantology; Chief Freelance Urologist of the Ministry of Health of the Nizhny Novgorod region, Chief Specialist in urology Nizhniy Novgorod, Russia; Nizhniy Novgorod, Russia

F. A Sevryukov

Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation; Private healthcare institution «Clinical Hospital «Russian Railways-Medicine»

Email: fedor_sevryukov@mail.ru
Dr.Sc.(M), Assoc. Prof. Professor at the E.V. Shakhov Department of Urology; Head of the Department of Urology Nizhniy Novgorod, Russia; Nizhniy Novgorod, Russia

D. S Ledyaev

Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation; Volga District Medical Center under Federal Medical and Biological Agency of Russia

Email: ledyaevd@gmail.com
Cand.Sc. (M), Docent of the Department of Faculty Surgery and Transplantology; Urologist of the Department of Urology CH3 Nizhniy Novgorod, Russia; Nizhniy Novgorod, Russia

V. E Gasrataliev

Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation; Volga District Medical Center under Federal Medical and Biological Agency of Russia

Email: Gasr.vadim@gmail.com
Cand.Sc.(M), Assistant of the Department of Faculty Surgery and Transplantology; Urologist of the Department of Urology 2 Nizhniy Novgorod, Russia; Nizhniy Novgorod, Russia

A. B Stroganov

Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation

Email: stroganov@pimunn.ru
Dr.Sc.(M), Docent of the Department of Faculty Surgery and Transplantology Nizhniy Novgorod, Russia

References

  1. Sorokin I., Mamoulakis C., Miyazawa K., Rodgers A., Talati J., Lotan Y. Epidemiology of stone disease across the world. World J. Urol. 2017;35(9):1301-1320. https://doi.org/10.1007/s00345-017-2008-6
  2. Апoлихин О.И., Сивгов А.В., Кoмарoва В.А., Прocянникoв М.Ю., Гoлoванoв C.A., Казаченко А.В., Никушина А.А., Шадеркина В.А. Забoлeваeмocть мoчeкамeннoй бoлeзнью в Рoccийcкoй Федерации (2005-2016). Экспериментальная и клиническая урoлoгия. 2018;4:4-14).
  3. Гаджиев Н.К., Бровкин С.С., Григорьев В.Е., Дмитриев В.В., Малхасян В.А., Шкарупа Д.Д., Писарев А.В., Мазуренко Д.А., Обидняк В.М., Орлов И.Н., Попов С.В., Тагиров Н.С., Петров С.В. Метафилактика мочекаменной болезни: новый взгляд, современный подход, мобильная реализация. Урология. 2017;1:124-129. https://dx.doi.org/10.18565/urol.2017.1.124-129
  4. Руденко В.И., Семенякин И.В., Малхасян В.А., Гаджиев Н.К. Мочекаменная болезнь. Урология. 2017;2:30-63). https://dx.doi.org/10.18565/urol.2017.2-supplement.30-63
  5. Григорьев Н.А., Семенякин И.В., Малхасян В.А., Гаджиев Н.К., Руденко В.И. Мочекаменная болезнь. Урология. 2016; 2:37-69).
  6. Дутов С.В., Мартов А.Г., Aндрoнoв А.С. Чрестжная нeфрoлитoтрипcия на спине. Урoлoгия. 2011;2:76-80).
  7. Гаджиев Н.К., Григорьев В.Е., Мазуренко Д.А., Малхасян В.А., Обидняк В.М., Писарев А.В., Тагиров Н.С., Попов С.В., Петров С.Б. Перкутанная нефролитотрипсия при сложных формах камней почек: структурное биомоделирование. Экспериментальная и клиническая урология. 2016;3:46-51).
  8. Меринов Д.С., Артемов А.В., Епишов В.А., Арустамов Л.Д., Гурбанов Ш.Ш., Фатихов Р.Р. Перкутанная нефролитотомия в лечении коралловидных камней почек. Экспериментальная и клиническая урология. 2016;3:57-62).
  9. Рогачиков В.В., Нестеров С.Н., Ильченко Д.Н., Тевлин К.П., Кудряшов А.В. Перкутанная нефролитолапаксия: прошлое, настоящее, будущее. Экспериментальная и клиническая урология. 2016;2:24-28).
  10. Türk С., Petnk А., Sarica К., Seitz С., Skolarikos A., Straub M., Knoll T. EAU Guidelines on Interventional Treatment for Urolithiasis. Eur. Urol. 2016;69(3):475-482. https://doi.org/10.1016/j.eururo.2015.07.041
  11. Мартов А.Г.,Дутов С.В., Попов С.В., Емельяненко А.В., Андронов А.С., Орлов И.Н. Микроперкутанная лазерная нефролитотрипсия. Урология. 2019;3:72-79). https://doi.org/10.18565/urology.2019.3.72-79
  12. Малхасян В.А., Семенякин И.В., Иванов В.Ю., Сухих С.О., Гаджиев Н.К. Обзор осложнений перкутанной нефролитотомии и методов их лечения. Урология. 2018;4:147-153.). https://dx.doi.org/10.18565/urology.2018.4.147-153
  13. Aminsharifi A., Irani D., Masoumi M., Goshtasbi B., Aminsharifi A., Mohamadian R. The management of large staghorn renal stones by percutaneous versus laparoscopic versus open nephrolithotomy: a comparative analysis of clinical efficacy and functional outcome. Urolithiasis. 2016;44(6):551-557. https://doi.org/10.1007/s00240-016-0877-6.
  14. Перепанова Т.С., Зырянов С.К., Соколов А.В., Тищенкова И.Ф., Меринов Д.С., Арустамов Л.Д., Круглов А.Н., Раджабов У.А. Поиск новых режимов антибиотикопрофилактики септических осложнений после перкутанной нефролитотрипсии. Урология. 2014;6:92-95.
  15. Bansal S.S., Pawar P.W., Sawant A.S., Tamhankar A.S., Patil S.R., Kasat G.V. Predictive factors for fever and sepsis following percutaneous nephrolithotomy: A review of 580 patients. Urol. Ann. 2017;9(3):230- 233. https://doi.org/10.4103/UA.UA_166_16.
  16. Koras O., Bozkurt I.H., Yonguc T., Degirmenci T., Arslan B., Gunlusoy B., Aydogdu O., Minareci S. Risk factors for postoperative infectious complications following percutaneous nephrolithotomy: a prospective clinical study. Urolithiasis. 2015;43(1):55-60. https://doi.org/10.1007/s00240-014-0730-8
  17. Gutierrez J., Smith A., Geavleteetal P. Urinary tract infections and post-operative fever in percutaneous nephrolithotomy. World Journal of Urology. 2013;31(5):1135-1140. https://doi.org/10.1007/s00345-012-0836-y.
  18. Kreydin E.I., Eisner B.H. Risk factors for sepsis after percutaneous renal stone surgery. Nature Reviews Urology. 2013; 10(10):598-605. https://doi.org/10.1038/nrurol.2013.183
  19. Kallidonis P., Panagopoulos V., Kyriazis I., Liatsikos E.Complications of percutaneous nephrolithotomy: classification, management, and prevention. Curr. Opin. Urol. 2016;26(1):88-94. https://doi.org/10.1097/mou.0000000000000232
  20. Keoghane S.R., Cetti R.J., Rogers A.E., Walmsley B.H. Blood transfusion, embolisation and nephrectomy after percutaneous nephrolithotomy (PCNL). BJU Int. 2013;111(4):628-632. https://doi.org/10.1111/j.1464-410x.2012.11394.x
  21. Un S., Cakir V., Kara C., Turk H. Risk factors for hemorrhage requiring embolization after percutaneous nephrolithotomy. Can. Urol. Assoc. J. 2015;9(10):594-598. https://doi.org/10.5489/cuaj.2803.
  22. Rizvi S.A.H., Hussain M., Askari S.H., Hashmi A., Lal M., Zafar M.N. Surgical outcomes of percutaneous nephrolithotomy in 3402 patients and results of stone analysis in 1559 patients. B.J.U.Int. 2017;120(5):703- 709. https://doi.org/10.1111/bju.13848.
  23. Мeринoв Д.C., Артeмoв А.В., Eпишoв В.А., Аруcтамoв Л.Д., Гурбанoв Ш.Ш., Пoликарпoва А.М. Мультипeркутанная нeфрoлитoтoмия в лeчeнии кoраллoвидных камнeй пoчeк. Урoлoгия. 2018;4:96-101.). https://dx.doi.org/10.18565/urology.2018.4.96-101.
  24. Chung D.Y., Kang D.H., Cho K.S., Jeong W.S., Jung H.D., Kwon J.K., Lee S.H., Le J.Y.Comparison of stone-free rates following shock wave lithotripsy, percutaneous nephrolithotomy, and retrograde intrarenal surgery for treatment of renal stones: A systematic review and network meta-analysis. PLoS One. 2019;14(2):e0211316. https://doi.org/10.1371/journal.pone.0211316
  25. Bernardo N., Silva M. Percutaneous renal access under fluoroscopic control. Smith’s Textbook of Endourology, 4-th Edition. - Somerset: Wiley-Blackwell. 2019;12:210-221.
  26. Patel S.R., Nakada S.Y. The modern history and evolution ofpercutaneous nephrolithotomy. J. Endourol. 2016;29(2): 153-157. https://doi.org/10.1089/end.2014.0287
  27. Tailly Т., Denstedt J. Innovations in percutaneous nephrolithotomy.Int. J. Surg. 2016;36:665-672. https://doi.org/10.1016/j.ijsu.2016.11.007.
  28. Taylor E.R., Kramer B., Frye T.P. Ocular radiation exposure in modern urological practice. J. Urol. 2013;190(1):139-143. https://doi.org/10.1016/j.juro.2013.01.081
  29. Wagner L.K., Eifel P.J., Geise R.A. Potential biological effects following high X-ray dose interventional procedures. J. Vasc.Interv. Radiol. 1994;5:71-84. https://doi.org/10.1016/s1051-0443(94)71456-1
  30. Rao P.N., Faulkner K., Sweeney L.K. Radiation dose to patient and staff during percutaneous nephrolithotomy. Br. J. Urol. 1987;59:508. https://doi.org/10.1111/j.1464-410x.1987.tb04864.x
  31. Smith D.L., Heldt J.P., Richards G.D. Radiation exposure during continuous and pulsed fluoroscopy. J. Endourol. 2013;27:384. https://doi.org/10.1089/end.2012.0213
  32. Chodick G., Bekiroglu N., Hauptmann M. Risk of cataract after exposure to low doses of ionizing radiation: a 20-year prospective cohort study among US radiologic technologists. Am. J. Epidemiol. 2008;168:620. https://doi.org/10.1093/aje/kwn171
  33. Milacic S. Risk of occupational radiation-induced cataract in medical workers. Med Lav. 2009;100:178.
  34. Ritter M., Krombach P., Martinschek A. Radiation exposure during endourologic procedures using over-the table fluoroscopy sources. J. Endourol. 2012;26:47. https://doi.org/10.1089/end.2011.0333
  35. Ghani K.R., Andonian S., Bultitude M., Desai M., Giusti G., Okhunov Z. Percutaneous nephrolithotomy: update, trends, and future directions. Eur. Urol. 2016;70(2):382- 396. https://doi.org/10.1016/j.eururo.2016.01.047
  36. Basiri А., Ziaee A.M., Kianian H.R Ultrasonographic versus fluoroscopic access for percutaneous nephrolithotomy: A randomized clinical trial. J. Endourol. 2008;22(2):281-284. https://doi.org/10.1089/end.2007.0141
  37. Gamal W.M., Hussein M., Aldasshoury M. Solo ultrasonography-guided percutaneous nephrolithotomy for single stone pelvis. J. Endourol. 2011;25(4):593-596. https://doi.org/10.1089/end.2010.0558
  38. Osman M., Wendt-Nordahl G., Neger K. Percutaneous nephrolithotomy with ultrasonography-guided renal access: Experience from over 300 cases. BJU Int. 2005;96:875-878. https://doi.org/10.1111/j.1464-410x.2005.05749.x
  39. Hosseini M., Hassanpour A., Farzan R. Ultrasonography-guided percutaneous nephrolithotomy. J. Endourol. 2009;23:603-607. https://doi.org/10.1089/end.2007.0213
  40. Desai M. Ultrasonography-guided punctures - with and without puncture guide. J. Endourol. 2009;23:1641-1643. https://doi.org/10.1089/end.2009.1530
  41. Гулиев Б.Г., Стецик Е.О. Чрескожное удаление камней почки под ультразвуковым контролем. Вестник Северо-Западного государственного медицинского университета. 2017;9(3):74-79.
  42. Atduev V., Ledyaev D., Dyrdik M., Abramov D. Percutaneous nephrolithotomy under X-ray control and totally ultrasound-guided percutaneous nephrolithotomy: The outcome comparison. Eur Urol Suppl. 2016;15(3):e574.
  43. Fei X., Li J., Song Y., Wu B. Single-stage multiple-tract percutaneous nephrolithotomy in the treatment of staghorn stones under total ultrasonography guidance. Urol.Int. 2017;93(4):411-416. https://doi.org/10.1159/000364834
  44. Dindo D., Clavien P.A. What is a surgical complication? World J Surg. 2008;32:939-941. https://doi.org/10.1007/s00268-008-9471-6
  45. Tefekli A., Karadag M., Tepeler K. Classification of percutaneous nephrolithotomy complications using the modified clavien grading system: looking for a standard. Eur Urol. 2008:53(1):184-90. https://doi.org/10.1016/j.eururo.2007.06.049
  46. Violette P.D.,Denstedt J.D. Standardizing the reporting of percutaneous nephrolithotomy complications. Indian J Urol. 2014;30( 1):84-91. https://doi.org/10.4103/0970-1591.124213
  47. Taylor E, Miller J, Chi T., Stoller M.L.Complications associated with percutaneous nephrolithotomy. Transl Androl Urol. 2012;1:223-228. https://dx.doi.org/10.3978%2Fj.issn.2223-4683.2012.12.01
  48. Oliveira J.M. Analysis of surgical complications of percutaneous nephrolythotomy, in the first three years, in a teaching hospital. Am J Clin Exp Urol 2021;9(6):497-503.
  49. Seitz C., Desai M., Häcker A., Hakenberg O.W., Liatsikos E., Nagele U., Tolleyet D. Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy. Eur Urol, 2012.61:146. https://doi.org/10.1016/j.eururo.2011.09.016

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies